|Scientific Subdivisions | The Journal of Molecular Diagnostics
Contact AMP | Sign In | Join / Renew | Go To CHAMP
Authors' Frequently Asked Questions
The direction of the JMD will continue to be shaped by the Journal's Editors, publishing "high-quality, original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine. The editors welcome for review articles that contain: novel discoveries or clinicopathologic correlations including studies in oncology, infectious diseases, inherited diseases, predisposition to disease, or the description or polymorphisms linked to disease states or normal variations; the application of diagnostic methodologies in clinical trials; or the development of new or improved molecular methods for diagnosis or monitoring of disease or disease predisposition."
Authors should continue to submit new and revised manuscripts online at Rapid Review (https://www.rapidreview.com/ASIP2/CALogon.jsp). In an unrelated move, the online submission interface was updated in November to improve the author experience.
The editorial decision-making process will remain with the Editor-in-Chief and Associate Editors. We will continue to seek expert review from experienced external reviewers to aid this process.
Author costs of publishing will remain the same ($65/page, $550/color figure, $50/black and white figure, $50/table, $65/supplemental file). As always, any future changes in publication costs will be announced in advance and will appear in revised Instructions to Authors.
Proofs will be provided by Elsevier via Cadmus Communications (Cenveo) via email for download, as in the past. You should follow the instructions therein for where to return your corrected pages.
The JMD (http://jmd.amjpathol.org) will remain online and in print form, at the same high quality you have come to expect.
The JMD will continue to deposit final published articles funded by NIH, HHMI, Wellcome Trust, and MRC in PubMed Central in compliance with each funding agency's requirements.